Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent

Published:2024-06 Issue:2 Volume:35 Page:102193
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Abdelaal Ahmed M.,Sohal Ikjot S.,Iyer Shreyas G.,Sudarshan Kasireddy,Orellana Esteban A.,Ozcan Kenan E.,dos Santos Andrea P.,Low Philip S.,Kasinski Andrea L.^ORCID

Funder

US Department of Defense

National Institutes of Health

Publisher

Elsevier BV

Reference43 articles.

1. MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy;Orellana;Cancers,2015

2. Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics;Myoung,2019

3. MicroRNA biogenesis pathways in cancer;Lin;Nat. Rev. Cancer,2015

4. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation;O’Brien;Front. Endocrinol.,2018

5. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy;Kasinski;Nat. Rev. Cancer,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the Performance and Accuracy of a PSA and PSA Ratio-Based Nomogram to Predict the Probability of Prostate Cancer in a Cohort of Patients with PIRADS 3 Findings at Multiparametric Magnetic Resonance Imaging;Cancers;2024-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP